Undesirable drug effects after taking chlormezanone ('Muskel Trancopal'®) with lethal outcome;Unerwunschte arzneimittelwirkung nach einnahme von chlormezanon (Muskel Trancopal®) mit letalem ausgang

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 28-29, 1998, Pages 866-870

  Boxberg, C V ^a,b   Breidenbach, K ^a,b   Hohler H ^a,b   Kobberling J ^a,b  

^a HELIOS KLINIKUM WUPPERTAL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; BILIRUBIN; CHLORMEZANONE; LIVER ENZYME; MUSKEL TRANCOPAL; PANCREAS ENZYME; UNCLASSIFIED DRUG; CENTRAL MUSCLE RELAXANT;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; ENZYME ACTIVITY; FEMALE; HUMAN; MULTIPLE ORGAN FAILURE; NECK PAIN; PANCREATITIS; PARENTERAL NUTRITION; RESPIRATORY FAILURE; SEPSIS; SHOULDER PAIN; TOXIC EPIDERMAL NECROLYSIS; ACUTE DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; CHEMICALLY INDUCED DISORDER; COLON; DRUG EFFECT; FATALITY; INTESTINE MUCOSA; PAIN; PATHOLOGY; SHOULDER; TOXIC HEPATITIS;

ACUTE DISEASE; ADULT; CHLORMEZANONE; COLON; EPIDERMAL NECROLYSIS, TOXIC; FATAL OUTCOME; FEMALE; HEPATITIS, TOXIC; HUMANS; INTESTINAL MUCOSA; MULTIPLE ORGAN FAILURE; MUSCLE RELAXANTS, CENTRAL; NECK PAIN; PAIN; PANCREATITIS; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOULDER;

EID: 0032503718     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024079     Document Type: Article

References (9)

1. Bourliere, M., Y. P. Le Treut, J. C. Manelli, D. Botta-Friedlund, J. G. Bertolino, L. Boubli, D. Sanson, R. Bricot, A. P. Gauthier: Chlormezanone-induced fulminant hepatitis in a pregnant woman. Successfull delivery and liver transplantation. J. Gastroenterol. Hepatol. 7 (1992), 339-341.
2. Braun-Falco, O., G. Plewig, H. H. Wolff: Dermatologie und Venerologie (Springer: Berlin 1995), 362-365.
3. Karch, F. E., L. Lasagna: Toward the operational identification of adverse drug reactions. Clin. Pharmacol. Ther. 21 (1977), 247-254.
4. Ohsawa, T., K. Konishi: Hepatitis associated with chlormezanone (letter). Drug Intell, clin. Pharm. 20 (1986), 506.
5. Pomiersky, C., E. Blaich: Arzneimittelbedingte Hepatitis mit Cholestase nach Therapie mit Chlormezanon. Z. Gastroenterol. 23 (1985), 684-686.
6. Rote Liste Service GmbH: Rote Liste 1996 (Editio Cantor: Aulendorf 1995), 64.029.
7. Roujeau, J. C., O. Chosidow, P. Saiag, J. C. Guillaume: Toxic epidermal necrolysis. J. Amer. Acad. Dermatol. 23 (1990), 1039-1058.
8. Roujeau, J. C., J. P. Kelly, L. Naldi, B. Rzanny, R. S. Stern, T. Anderson, A. Auquirev, S. Bastuji-Garin, O. Correia, F. Locati, M. Mockenhaupt, C. Paoletti, S. Shapiro, N. Shear, E. Schöpf, D. W. Kaufman: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. New Engl. J. Med. 333 (1995), 1600-1607.
9. Rzany, B., M. Mockenhaupt, S. Baur, U. Stocker, E. Schöpf: Schwere Hautreaktionen. Hautarzt 44 (1993), 549-556.